Funded Research

The MRF has funded millions of dollars in melanoma research since 1998.

The Melanoma Research Foundation is proud to award research grants supporting the study of melanoma prevention, diagnosis and treatment across the spectrum of the disease, including cutaneous, ocular and mucosal melanoma. These include the following:

  • Team Awards (established in 2014) - Two-year awards, up to 0,000 per year
  • Established (Senior) Investigator Awards (established in 2006) - Two-year awards, up to 0,000 per year
  • Career Development (Junior) Awards (established in 1998) - Two-year awards, up to ,000 per year
  • Medical Student Awards (established in 2011) - One-year awards, up to ,000
  • Society for Melanoma Research Young Investigator Awards (sponsored by the MRF since 2013) - One-year awards, ,000 per year
  • Society for Melanoma Research Christopher J. Marshall Award (sponsored by the MRF since 2015) - One-year awards, ,000 per year

View a summary of the 2019 Research Recipients here.

TIGIT-mediated regulation of immune suppression in melanoma

Career Development Award 2013
Principal Investigator: Dr. Ana Anderson
Institution: Brigham and Women's Hospital
Career Development Award


Assessing TSPY as a marker for melanoma progression in men

Medical Student Award 2012
Principal Investigator: Jillian W. Wong
Institution: University of Utah Medical School
In memory of Robert Hansen and Brad Lanpher


Soluble adenylyl cyclase regulates melanoma through autophagy

Medical Student Award 2012
Principal Investigator: Adam J. Widman
Institution: Weill Cornell Medical College
Medical Student Award – In memory of Thomas Gutheil


Treatment outcomes with bevacizumab and triamcinolone for posterior uveal melanoma in patients undergoing I-125 plaque brachytherapy

Medical Student Award 2012
Principal Investigator: Nisha V. Shah
Institution: University of Miami Miller School of Medicine
Medical Student Award – In honor of participants in the Suncoast Miles for Melanoma


Measurement of macrophage derived interferon gamma levels in melanoma patients post UV radiation exposure

Medical Student Award 2012
Principal Investigator: Tatyana Petukhova
Institution: Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Medical Student Award – In memory of George Wilkins


RTK coactiviation in BRAF inhibitor resistant melanomas

Medical Student Award 2012
Principal Investigator: Elisha Garg
Institution: David Geffen School of Medicine at UCLA
Medical Student Award – In honor of Dancers United Concert for a Cause


Targeting TBK1 in mutant NRAS melanoma

Established Investigator Award 2012
Principal Investigator: Dr. Andrew Aplin
Institution: Thomas Jefferson University
In honor of participants in Wings of Hope, San Francisco


Optimizing combined targeted and immune melanoma therapies

Career Development Award 2012
Principal Investigator: Dr. Marcus Bosenberg
Institution: Yale University
In honor of participants in Wings of Hope, DC – 3 year award in conjunction with the Melanoma Research Alliance


MT1-MMP as a target for treating melanoma

Career Development Award 2012
Principal Investigator: Dr. Barbara Bedogni
Institution: Case Western Reserve University-School of Medicine
In memory of Amanda Carter-Horn and in honor of Neil Gaines and the participants in the Mela-no-no and Central Ohio Pasta Dinner fundraisers


The role of cell polarity in metastatic melanoma

Career Development Award 2012
Principal Investigator: Dr. Eric Witze
Institution: The Trustees of the University of Pennsylvania
In memory of Terry Patters and Yvette M. Jarvis